Novo Nordisk Pink Sheet Forecast - Simple Regression
| NONOF Stock | USD 105.00 2.16 2.10% |
The Simple Regression forecasted value of Novo Nordisk AS on the next trading day is expected to be 100.32 with a mean absolute deviation of 2.86 and the sum of the absolute errors of 174.32. Novo Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Novo Nordisk's historical fundamentals, such as revenue growth or operating cash flow patterns.
Novo |
Novo Nordisk Simple Regression Price Forecast For the 26th of November
Given 90 days horizon, the Simple Regression forecasted value of Novo Nordisk AS on the next trading day is expected to be 100.32 with a mean absolute deviation of 2.86, mean absolute percentage error of 12.58, and the sum of the absolute errors of 174.32.Please note that although there have been many attempts to predict Novo Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Novo Nordisk's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Novo Nordisk Pink Sheet Forecast Pattern
| Backtest Novo Nordisk | Novo Nordisk Price Prediction | Buy or Sell Advice |
Novo Nordisk Forecasted Value
In the context of forecasting Novo Nordisk's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Novo Nordisk's downside and upside margins for the forecasting period are 97.74 and 102.90, respectively. We have considered Novo Nordisk's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Novo Nordisk pink sheet data series using in forecasting. Note that when a statistical model is used to represent Novo Nordisk pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.6424 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.8577 |
| MAPE | Mean absolute percentage error | 0.0239 |
| SAE | Sum of the absolute errors | 174.3223 |
Predictive Modules for Novo Nordisk
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novo Nordisk AS. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Novo Nordisk
For every potential investor in Novo, whether a beginner or expert, Novo Nordisk's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Novo Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Novo. Basic forecasting techniques help filter out the noise by identifying Novo Nordisk's price trends.View Novo Nordisk Related Equities
| Risk & Return | Correlation |
Novo Nordisk AS Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Novo Nordisk's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Novo Nordisk's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Novo Nordisk Market Strength Events
Market strength indicators help investors to evaluate how Novo Nordisk pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk pink sheet market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns.
Novo Nordisk Risk Indicators
The analysis of Novo Nordisk's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Novo Nordisk's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting novo pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.06 | |||
| Standard Deviation | 2.55 | |||
| Variance | 6.5 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Novo Pink Sheet
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:Check out Historical Fundamental Analysis of Novo Nordisk to cross-verify your projections. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.